Evidence map›Paper›PMID 25371820›Full record

ArticleJournal of signal transduction2014

Signaling Network Map of Endothelial TEK Tyrosine Kinase.

Aafaque Ahmad Khan, Varot K Sandhya, Priyata Singh, Deepak Parthasarathy, Awinav Kumar, Jayshree Advani, Rudrappa Gattu, Dhanya V Ranjit, Rama Vaidyanathan, Premendu Prakash Mathur and 5 more

Abstract read
In one paragraph

Article in Journal of signal transduction, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. A genome-wide by PMScientific reports · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. A network map of thrombopoietin signaling.Journal of cell communication and signaling · 2018
    Article
  13. Article
  14. BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?TH open : companion journal to thrombosis and haemostasis · 2018
    Review
  15. Article
  16. Article
  17. A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy.International journal of molecular sciences · 2017
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Aafaque Ahmad KhanInstitute of Bioinformatics, International Tech Park, Whitefield, Bangalore 560066, India ; School of Biotechnology, KIIT University, Bhubaneswar 751024, India.ORCID 0000-0002-8127-9677
Varot K SandhyaInstitute of Bioinformatics, International Tech Park, Whitefield, Bangalore 560066, India.
Priyata SinghDr. M.G.R. Educational and Research Institute, Maduravoyal, Chennai 600095, India.
Deepak ParthasarathyDr. M.G.R. Educational and Research Institute, Maduravoyal, Chennai 600095, India.
Awinav KumarDr. M.G.R. Educational and Research Institute, Maduravoyal, Chennai 600095, India.
Jayshree AdvaniInstitute of Bioinformatics, International Tech Park, Whitefield, Bangalore 560066, India ; Manipal University, Madhav Nagar, Manipal 576104, India.ORCID 0000-0003-1416-4922
Rudrappa GattuInstitute of Bioinformatics, International Tech Park, Whitefield, Bangalore 560066, India ; School of Biotechnology, KIIT University, Bhubaneswar 751024, India.
Dhanya V RanjitInstitute of Bioinformatics, International Tech Park, Whitefield, Bangalore 560066, India.ORCID 0000-0001-8193-9551
Rama VaidyanathanDr. M.G.R. Educational and Research Institute, Maduravoyal, Chennai 600095, India.ORCID 0000-0001-8823-8053
Premendu Prakash MathurSchool of Biotechnology, KIIT University, Bhubaneswar 751024, India.
T S Keshava PrasadInstitute of Bioinformatics, International Tech Park, Whitefield, Bangalore 560066, India.ORCID 0000-0002-6206-2384
F Mac GabhannDepartment of Biomedical Engineering and Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD 21218, USA.
Akhilesh PandeyInstitute of Bioinformatics, International Tech Park, Whitefield, Bangalore 560066, India ; McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA ; Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA ; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA ; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Rajesh RajuInstitute of Bioinformatics, International Tech Park, Whitefield, Bangalore 560066, India.ORCID 0000-0003-2319-121X
Harsha GowdaInstitute of Bioinformatics, International Tech Park, Whitefield, Bangalore 560066, India.ORCID 0000-0002-4118-6855

Funding

Wellcome Trust
6 · The paper itself

Abstract

TEK tyrosine kinase is primarily expressed on endothelial cells and is most commonly referred to as TIE2. TIE2 is a receptor tyrosine kinase modulated by its ligands, angiopoietins, to regulate the development and remodeling of vascular system. It is also one of the critical pathways associated with tumor angiogenesis and familial venous malformations. Apart from the vascular system, TIE2 signaling is also associated with postnatal hematopoiesis. Despite the involvement of TIE2-angiopoietin system in several diseases, the downstream molecular events of TIE2-angiopoietin signaling are not reported in any pathway repository. Therefore, carrying out a detailed review of published literature, we have documented molecular signaling events mediated by TIE2 in response to angiopoietins and developed a network map of TIE2 signaling. The pathway information is freely available to the scientific community through NetPath, a manually curated resource of signaling pathways. We hope that this pathway resource will provide an in-depth view of TIE2-angiopoietin signaling and will lead to identification of potential therapeutic targets for TIE2-angiopoietin associated disorders.

Identifiers

PMID25371820
PMCPMC4211299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.